Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
about
Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy.Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.Locomotor and skeletal muscle abnormalities in trembler J neuropathic mice.A Neurogenic Perspective of Sarcopenia: Time Course Study of Sciatic Nerves From Aging Mice.
P2860
Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@en
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@nl
type
label
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@en
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@nl
prefLabel
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@en
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@nl
P2093
P2860
P356
P1433
P1476
Biochemical characterization o ...... the C22 mouse model of CMT1A.
@en
P2093
Diana C Narvaez
Irina Madorsky
Jessica R Nicks
Jordan T Schmidt
Lee Sooyeon
Lucia Notterpek
Sunitha Rangaraju
P2860
P304
P356
10.1042/AN20130024
P577
2013-12-03T00:00:00Z